home / United States / ACADIA Pharmaceuticals

ACADIA Pharmaceuticals Market Cap

$2.50 B

+21.68 M

NASDAQ:ACAD · April 16, 2025

Share price

$14.99

Enterprise Value

$1.77 B

Change (1-Year)

9.8%

Global Rank

#3627

Country Rank

#1310

Regions

USA

Market cap

As of April 16, 2025, ACADIA Pharmaceuticals (ACAD) has a market cap of $2.50 billion USD. According to our data, ACADIA Pharmaceuticals is ranked No.3627 in global market value.

Sector Rank:

Biotech #174 Pharmaceuticals #163

ACAD Market Capitalization Growth

1 Years Growth:

9.8%

3 Years Growth:

-15.8%

5 Years Growth:

-61.4%

10 Years Growth:

-50.4%

15 Years Growth:

1030.5%

20 Years Growth:

164.1%

Total Growth:

182%

ACADIA Pharmaceuticals Market Cap Chart

YTD

10Y

15Y

20Y

MAX

ACADIA Pharmaceuticals Market Cap CAGR Chart

ACADIA Pharmaceuticals Market Cap History 2004 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$2.50 B	-18.12%
Dec 31, 2024	$3.05 B	-41.39%
Dec 29, 2023	$5.21 B	96.67%
Dec 30, 2022	$2.65 B	-31.79%
Dec 31, 2021	$3.88 B	-56.34%
Dec 31, 2020	$8.90 B	24.96%
Dec 31, 2019	$7.12 B	164.56%
Dec 31, 2018	$2.69 B	-46.30%
Dec 29, 2017	$5.01 B	4.40%
Dec 30, 2016	$4.80 B	-19.10%
Dec 31, 2015	$5.93 B	12.28%
Dec 31, 2014	$5.28 B	27.05%
Dec 31, 2013	$4.16 B	437.42%
Dec 31, 2012	$0.77 B	330.56%
Dec 30, 2011	$0.18 B	-10.00%
Dec 31, 2010	$0.20 B	-9.09%
Dec 31, 2009	$0.22 B	46.67%
Dec 31, 2008	$0.15 B	-91.87%
Dec 31, 2007	$1.84 B	25.94%
Dec 29, 2006	$1.46 B	-10.76%
Dec 30, 2005	$1.64 B	45.49%
Dec 31, 2004	$1.13 B	100%

Similar Companies to ACADIA Pharmaceuticals

Name	Market Cap	Market cap difference	Regions
Neurocrine Biosciences NBIX	$9.51 B	0.000 M	USA
Intra-Cellular Therapies ITCI	$14.05 B	0.000 M	USA
Biogen BIIB	$17.12 B	0.000 M	USA
Eli Lilly LLY	$679.94 B	-0.022 M	USA
Johnson & Johnson JNJ	$370.20 B	0.003 M	USA
Teva Pharmaceutical Industries TEVA	$15.60 B	0.000 M	Israel
Amgen AMGN	$158.77 B	0.132 B	USA
Pfizer PFE	$127.27 B	-0.003 M	USA
AstraZeneca AZN	$210.42 B	-0.005 M	UK
First Majestic Silver AG	$3.20 B	0.851 M	Canada
Bristol-Myers Squibb BMY	$101.74 B	-0.001 M	USA
Merck MRK	$197.26 B	0.003 M	USA
AbbVie ABBV	$312.76 B	-0.013 M	USA

About ACADIA Pharmaceuticals Inc.

Name

ACADIA Pharmaceuticals Inc.

Website

https://www.acadia.com

Headquarters

San Diego,CA

symbol

ACAD

CURRENCY

USD

country

United States

fullTimeEmployees

653

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

ACAD Market Cap Formula

Market Cap	=	ACAD Stock Price	*	ACAD Shares Outstanding
	=	$14.99	*	0.17 B
	=	$2.50 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe